BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22549292)

  • 1. [Current approaches in multiple myeloma and other cancer-related bone diseases].
    Engelhardt M; Kleber M; Udi J; Wäsch R
    Dtsch Med Wochenschr; 2012 May; 137(20):1057-61. PubMed ID: 22549292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in imaging and the management of myeloma bone disease.
    Terpos E; Moulopoulos LA; Dimopoulos MA
    J Clin Oncol; 2011 May; 29(14):1907-15. PubMed ID: 21483016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of bone disease in multiple myeloma].
    Izumi T
    Gan To Kagaku Ryoho; 2012 Aug; 39(8):1187-90. PubMed ID: 22902442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma.
    Terpos E; Dimopoulos MA; Sezer O
    Leukemia; 2007 Sep; 21(9):1875-84. PubMed ID: 17611556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-body low-dose computed tomography and advanced imaging techniques for multiple myeloma bone disease.
    Pianko MJ; Terpos E; Roodman GD; Divgi CR; Zweegman S; Hillengass J; Lentzsch S
    Clin Cancer Res; 2014 Dec; 20(23):5888-97. PubMed ID: 25294899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of bone disease in multiple myeloma.
    Terpos E; Berenson J; Raje N; Roodman GD
    Expert Rev Hematol; 2014 Feb; 7(1):113-25. PubMed ID: 24433088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging patients with myeloma.
    Winterbottom AP; Shaw AS
    Clin Radiol; 2009 Jan; 64(1):1-11. PubMed ID: 19070692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis and management of myeloma bone disease.
    Christoulas D; Terpos E; Dimopoulos MA
    Expert Rev Hematol; 2009 Aug; 2(4):385-98. PubMed ID: 21082944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic use of immunomodulatory drugs in the treatment of multiple myeloma.
    Raje N; Hideshima T; Anderson KC
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1239-47. PubMed ID: 17020458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simplified response monitoring criteria for multiple myeloma in patients undergoing therapy with novel agents using computed tomography.
    Schabel C; Horger M; Kum S; Weisel K; Fritz J; Ioanoviciu SD; Bier G
    Eur J Radiol; 2016 Dec; 85(12):2195-2199. PubMed ID: 27842666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide and lenalidomide in multiple myeloma.
    Mazumder A; Jagannath S
    Best Pract Res Clin Haematol; 2006; 19(4):769-80. PubMed ID: 16997182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloma bone disease: pathogenesis, current treatments and future targets.
    Walker RE; Lawson MA; Buckle CH; Snowden JA; Chantry AD
    Br Med Bull; 2014 Sep; 111(1):117-38. PubMed ID: 25190762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future drug developments in multiple myeloma: an overview of novel lenalidomide-based combination therapies.
    Morgan G
    Blood Rev; 2010 Nov; 24 Suppl 1():S27-32. PubMed ID: 21126634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lenalidomide and thalidomide: mechanisms of action--similarities and differences.
    Anderson KC
    Semin Hematol; 2005 Oct; 42(4 Suppl 4):S3-8. PubMed ID: 16344099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of the magnetic resonance in diagnosis of multiple myeloma].
    Dytfeld D; Sosnowski P; Czyz A; Komarnick M
    Pol Merkur Lekarski; 2007 Aug; 23(134):85-8. PubMed ID: 18044333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myeloma.
    Laubach JP; Schlossman RL; Mitsiades CS; Anderson KC; Richardson PG
    Expert Rev Hematol; 2011 Feb; 4(1):51-60. PubMed ID: 21322778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.
    Dimopoulos M; Terpos E; Comenzo RL; Tosi P; Beksac M; Sezer O; Siegel D; Lokhorst H; Kumar S; Rajkumar SV; Niesvizky R; Moulopoulos LA; Durie BG;
    Leukemia; 2009 Sep; 23(9):1545-56. PubMed ID: 19421229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloma bone disease and treatment options.
    Yeh HS; Berenson JR
    Eur J Cancer; 2006 Jul; 42(11):1554-63. PubMed ID: 16797971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drugs for myeloma.
    Richardson PG; Mitsiades C; Schlossman R; Munshi N; Anderson K
    Oncologist; 2007 Jun; 12(6):664-89. PubMed ID: 17602058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.